Company: EHC
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000785161-25-000009
Chunk: 161

Company: Encompass Health Corp
Filing Date: 2025-02-28
Form: 10-K
Item: Item 7
Chunk 161
---
 statements.

Our Adjusted EBITDA was as follows (in millions):

Reconciliation of Net Cash Provided by Operating Activities to Adjusted EBITDA

 For the Year Ended December 31, 202420232022Net cash provided by operating activities$1,002.8 $850.8 $705.8 Interest expense and amortization of debt discounts and fees137.4 143.5 175.7 Gain (loss) on sale of investments, excluding impairments2.7 4.6 (15.5)Equity in net income of nonconsolidated affiliates3.0 3.2 2.9 Net income attributable to noncontrolling interests in continuing operations(140.9)(111.0)(93.6)Amortization of debt-related items(9.7)(9.5)(9.7)Distributions from nonconsolidated affiliates(4.0)(1.6)(4.0)Current portion of income tax expense139.5 128.3 72.2 Change in assets and liabilities(21.9)(50.3)30.4 Cash used in (provided by) operating activities of discontinued operations3.1 16.0 (52.3)Asset impairment impact on noncontrolling interests(7.3)— — State regulatory change impact on noncontrolling interests— (2.2)— Change in fair market value of equity securities(1.0)(0.7)7.4 Adjusted EBITDA$1,103.7 $971.1 $819.3 

65

Reconciliation of Net Income to Adjusted EBITDA

 For the Year Ended December 31, 202420232022Net income$596.6 $463.0 $365.9 Loss (income) from discontinued operations, net of tax, attributable to Encompass Health2.8 12.0 (15.2)Net income attributable to noncontrolling interests included in continuing operations(140.9)(111.0)(93.6)Provision for income tax expense150.2 132.2 100.1 Interest expense and amortization of debt discounts and fees137.4 143.5 175.7 Loss on early extinguishment of debt0.6 — 1.4 Loss on disposal or impairment of assets17.4 9.8